Medicortex Finland Oyj

Turku, Finland

Medicortex Finland is developing the first, non-invasive, point-of-care diagnostic test for Traumatic Brain Injury.

$2.1M raised

Oct 2022

Grant

Biotechnology Clinical Trials Health Care Medical

Top Investors

European Innovation Council U.S. Department of War Ran Weinstock

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Medicortex Finland Oyj

How much funding has Medicortex Finland Oyj raised?

Medicortex Finland Oyj has raised $2.1M in total funding. The most recent round was Grant. The last funding was announced in October 2022.

Who are Medicortex Finland Oyj's investors?

Medicortex Finland Oyj's investors include European Innovation Council, U.S. Department of War, Ran Weinstock.

Where is Medicortex Finland Oyj headquartered?

Medicortex Finland Oyj is headquartered in Turku, Finland.

What does Medicortex Finland Oyj do?

Medicortex Finland is developing the first, non-invasive, point-of-care diagnostic test for Traumatic Brain Injury.

What stage is Medicortex Finland Oyj at?

Medicortex Finland Oyj is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 25, 2022.

MLA

"Medicortex Finland Oyj — Funding & Investors." VCBacked, October 25, 2022, https://www.vcbacked.co/company/medicortex-finland-oyj. Accessed July 1, 2026.

APA

VCBacked. (2022). Medicortex Finland Oyj — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/medicortex-finland-oyj

Wikipedia (cite web)

{{cite web |title=Medicortex Finland Oyj — Funding & Investors |url=https://www.vcbacked.co/company/medicortex-finland-oyj |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 25, 2022.